Skip to main content
Figure 1 | Health and Quality of Life Outcomes

Figure 1

From: Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study

Figure 1

Changes in patient-reported outcomes (PROs) over 24 months in the CHOICE study. Changes from baseline in PRO measures over 24 months after initiation of exenatide twice daily (BID) or insulin are presented. The number of patients with change data at each time point is presented below the time point. a) Mean change in standardised Impact of Weight on Quality of Life-Lite (IWQOL-Lite) total score. b) Mean change in EuroQoL-5-Dimension (EQ-5D) index score. c) Mean change in EuroQoL-visual analogue scale (EQ-VAS) score. d) Mean changes in standardised Diabetes Health Profile-18 (DHP-18) scores. e) Mean change in Hospital Anxiety and Depression Scale (HADS) scores.

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us